Deviations from “Good Manufacturing Practices” the rule/ the Australian
An FDA inspection uncovered multiple significant deviations from standard manufacturing processes, termed “good manufacturing practices” at CSL (previously known as Commonwealth Serum Laboratories, and previously an Australian government lab) in its manufacture of flu vaccine for the US market. As is standard in these cases, a disclaimer was made to the effect that there is…